Ausiello Dennis A 4
4 · Rani Therapeutics Holdings, Inc. · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Rani Therapeutics Director Dennis Ausiello Receives Award 123,600 Shares
What Happened Dennis A. Ausiello, a director of Rani Therapeutics (RANI), was granted a derivative equity award covering 123,600 shares on May 28, 2026. The Form 4 records the acquisition price as $0.00 (total $0), and the award is described in the filing as an option-like grant rather than an open‑market purchase or sale.
Key Details
- Transaction date: 2026-05-28; filing date: 2026-06-01 (timely Form 4 filing).
- Instrument: Derivative award (option) for 123,600 shares; recorded price $0.00.
- Shares owned after transaction: Not disclosed in this Form 4.
- Footnote: The award vests in full on the first anniversary of the grant, subject to continuous service; earlier full vesting occurs upon the Company's next annual stockholder meeting or a Change in Control, subject to continuous service (per the 2021 Equity Incentive Plan).
- No sale or immediate cashless exercise reported.
Context This report reflects a grant of equity-based compensation (an option award) to a director. Such grants are routine for executive and director compensation and are distinct from open-market purchases or sales — they do not by themselves indicate buying or selling sentiment. The footnote clarifies vesting and potential acceleration events (annual meeting or change in control).
Insider Transaction Report
- Award
Director Stock Option (Right to Buy)
[F1]2026-05-28+123,600→ 123,600 totalExercise: $0.95Exp: 2036-05-27→ Class A Common Stock (123,600 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan (the "2021 Plan")) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Plan), each subject to the Reporting Person's Continuous Service through such date.